华昌化工9月17日获融资买入579.08万元，融资余额3.14亿元

Core Viewpoint - Huachang Chemical's stock performance shows a slight increase, but financial metrics indicate significant declines in revenue and net profit, suggesting potential challenges ahead for the company [1][2]. Financial Performance - As of June 30, Huachang Chemical reported a revenue of 3.217 billion yuan, a year-on-year decrease of 24.03% [2]. - The net profit attributable to shareholders was 10.9243 million yuan, reflecting a substantial year-on-year decline of 97.58% [2]. Shareholder and Market Activity - As of September 17, the total number of shareholders was 49,700, a decrease of 6.81% from the previous period [2]. - The average number of circulating shares per shareholder increased by 7.30% to 18,865 shares [2]. - On September 17, Huachang Chemical's financing buy amounted to 5.7908 million yuan, while financing repayment was 9.5161 million yuan, resulting in a net financing outflow of 3.7253 million yuan [1]. Dividend Distribution - Since its A-share listing, Huachang Chemical has distributed a total of 1.708 billion yuan in dividends, with 857 million yuan distributed over the past three years [3]. Institutional Holdings - As of June 30, 2025, the fourth largest circulating shareholder is the Southern CSI 1000 ETF, holding 5.274 million shares, an increase of 986,700 shares from the previous period [3]. - The Hong Kong Central Clearing Limited is the sixth largest circulating shareholder, holding 4.3969 million shares, a decrease of 2.5688 million shares from the previous period [3].